Cleveland Clinic London’s Post

The importance of decentralized care for patients and Greek healthcare system and the need to extend home treatment program OIKOTHEN to all eligible oncology Greek hospitals/ clinics, as well as to other therapeutic categories, such as Multiple Sclerosis, was highlighted at the Panhellenic Conference on Health Economics and Policy in the context of the roundtable "New standards of decentralized health care: The case of OIKOTHEN." During her speech, Angeliki Angeli, Chief Portfolio Value Officer, Roche Hellas, stressed the importance and the high value of continuous partnership and collaboration between all stakeholders in order to improve patients' lives and upscale the Greek healthcare system. Learn more at https://lnkd.in/e8phbuqk

New breakthroughs in ALS research are giving hope to patients and families. Dr. Stephen Kolb is at the forefront, working tirelessly to slow ALS progression and improve lives. Read more about his compassionate journey & innovative approach: https://go.osu.edu/Cq3X

Communication is so important in our everyday lives, and Dr. Leaman is making an impact in aphasia care. Learn more about one of our recent awardees.

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, led an informative discussion with James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; Robert Mancini PharmD, BCOP, FHOPA and Shawn Griffin, PharmD, BCOP in our newest Peer Exchange video series, centered around the latest advancements in Myelofibrosis treatments. Optimize the interdisciplinary care journey for Myelofibrosis patients – join the conversation and align with expert perspectives! >> https://bit.ly/3H9XsdL

Blood-based CRC screening is easy and less invasive than other traditional methods. Getting screened is so important and anyone age 45+ should get screened and have a baseline for future screenings. Let's get tested and increase survival rates!

Come to join us at #EuropeanExpertPE meeting in Mainz Oct24. Highest PE experts covering a top scientific program about this life threatening disease, with an overall focus on a #multidisciplinaryapproach, ranging from diagnosis to #interventionaltherapies. At Boston Scientific we are committed to the scientific community to improve PE outcomes, so do not hesitate to contact us if you would like more information about our value proposition. #ExpertPE #PulmonaryEmbolism #CatheterDirectedTherapies #USAT

Measuring outcomes that matter to patients: PIVOTing to Patient-Focused Drug Development in COPD and other chronic lung diseases Patient-Inspired Validation of Outcome Tools

Thankful for the opportunity to present with Tufts Medical Center at ICCAI 2024. With significant adverse outcomes of interventions like TAVR (10% to 20% mortality at 1 year), enhanced long term risk stratification might be useful, especially in managing elderly & frail populations, optimizing outcomes and reducing waste. The conference is hosted by the Society for Complex Acute Illness. The word “complex” here is key to our narrative, as acute illness involves multiorgan dysregulation that can be seen in loss of signal complexity at multiple time scales associated with the breakdown of nonlinear regulatory feedback loops. Our results show that selected beat scales may optimize measurement of the change in information content embedded in BP waveforms (via entropy metrics) showing different cardiac contractile function and vascular systemic elastance, which variables may directly affect outcomes. Special Thanks to Ebenezer Tolman, Ethan Brovman, Sage Tuchsen, Emery Amtmann and Timothy Ruchti

The SAFE-MCS study results were finally published and released this past weekend at #CRT2024! The Saranas Early Bird Bleed Detection Monitor helped with reducing bleeding events in patients undergoing complex PCI’s with MCS (mechanical circulatory support). This is a great initiative in driving patient safety! I am happy to have been apart of working with all of the physicians, nurses, and other staff members that made the SAFE-MCS study possible! 4.2 % BARC III/V Bleed rate vs. the historical 12.5% in the Protect II study. Correlated to a 66.3 relative reduction in severe bleeding events.

The medical insights are an important piece in the machinery of the consumer health business in order to be effective and safe. #cardiovascularhealth #prevention #cardioaspirina